Serial integrated (18)F-fluorodeoxythymidine PET/CT monitoring neoadjuvant chemotherapeutic response in invasive ductal carcinoma.
Beresford
Mark
M
Marie Curie Research Wing, Mount Vernon Cancer Centre, Northwood, Middlesex, UK.
Lyburn
Iain
I
Sanghera
Bal
B
Makris
Andreas
A
Wong
Wai-Lup
WL
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology*; D003520:Cyclophosphamide / Q000009:adverse effects; D015224:Dideoxynucleosides; D016903:Drug Monitoring / Q000379:methods*; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005462:Fluorine Radioisotopes; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009361:Neoplasm Invasiveness; D049268:Positron-Emission Tomography; D014057:Tomography, X-Ray Computed
D000903:Antibiotics, Antineoplastic; D000964:Antimetabolites, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D015224:Dideoxynucleosides; D005462:Fluorine Radioisotopes; D015251:Epirubicin; D003520:Cyclophosphamide; C002854:alovudine; D005472:Fluorouracil